VXX-401 / Vaxxinity  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
VXX-401 / Vaxxinity
NCT05762276: A Study to Investigate the Safety, Tolerability, Immunogenicity, and Pharmacodynamics of VXX-401 Administered IM in Adult Participants

Active, not recruiting
1
64
RoW
VXX-401, Placebo
Vaxxinity, Inc., Novotech (Australia) Pty Limited
Hypercholesterolemia
06/24
06/24

Download Options